Clincosm LogoSign in Get a demo

Castration-resistant Prostate Cancer

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +8 more
    • XmAb®808
    • Keytruda® (pembrolizumab)
    • Denver, Colorado
    • +2 more
    Jan 19, 2023

    Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)

    Completed
    • Prostatic Neoplasms
    • +3 more
    • Exercise
    • Ghent, Oost-Vlaanderen, Belgium
      University Hospital ghent
    Dec 22, 2022

    Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML

    Recruiting
    • Castration-resistant Prostate Cancer
    • Homologous Recombination Deficiency
    • Testosterone Enanthate 100 MG/ML Injectable Solution
    • Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
    • Sydney, New South Wales, Australia
      Kinghorn Cancer Centre, St. Vincent's Hospital
    Dec 16, 2022

    Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

    Recruiting
    • Castration-resistant Prostate Cancer
    • +2 more
    • pTVG-HP
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 21, 2022

    Bone Marrow Suppression and Recovery During Radionuclide

    Completed
    • Castration-resistant Prostate Cancer
    • Blood sampling
    • Copenhagen, Denmark
      Rigshospitalet
    Nov 4, 2022

    Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)

    Not yet recruiting
    • Castration-Resistant Prostate Cancer
    • SHR3680 tablets
    • (no location specified)
    Nov 1, 2022

    Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

    Active, not recruiting
    • Castration-resistant Prostate Cancer
    • +2 more
    • Tucson, Arizona
    • +19 more
    Oct 18, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

    Enrolling by invitation
    • Castration-resistant Prostate Cancer
    • Wuxi, Jiangsu, China
      Jiangnan University
    Sep 18, 2022

    Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)

    Active, not recruiting
    • Prostate Cancer
    • Castration-resistant Prostate Cancer
    • São Paulo, SP, Brazil
      Instituto do Câncer do Estado de São Paulo
    Sep 14, 2022

    Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Sep 6, 2022

    How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

    Recruiting
    • Castration-resistant Prostate Cancer
    • Radium-223 dichloride (Xofigo, BAY88-8223)
    • Multiple Locations, Taiwan
      Many locations
    Aug 19, 2022

    Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

    Terminated
    • Pancreatic Adenocarcinoma
    • +13 more
    • San Francisco, California
    • +7 more
    Aug 17, 2022

    Prostate Cancer, Castration-resistant Prostate Cancer Trial in Washington, Baltimore (Olaparib, Vitamin C)

    Not yet recruiting
    • Prostate Cancer
    • Castration-resistant Prostate Cancer
    • Washington, District of Columbia
    • +1 more
    Aug 12, 2022

    Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Metastatic Cancer
    • (no location specified)
    Aug 12, 2022

    Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

    Active, not recruiting
    • Metastatic Prostate Cancer
    • +4 more
    • Duarte, California
    • +26 more
    Aug 3, 2022

    Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

    Active, not recruiting
    • Castration-Resistant Prostate Cancer
    • Greenville, South Carolina
    • +4 more
    Aug 2, 2022

    Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

    Terminated
    • Metastatic Prostate Adenocarcinoma
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Jul 18, 2022

    Circulating Tumor Cells in High Risk and Early Metastatic

    Recruiting
    • High Risk Prostate Carcinoma
    • +3 more
    • Blood collection
    • Bala-Cynwyd, Pennsylvania
    • +1 more
    Jun 28, 2022

    Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

    Recruiting
    • Prostate Cancer
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins Hospital
    May 6, 2022

    Breast Cancer, Castration-resistant Prostate Cancer Trial in Ottawa (Bone modifying agent)

    Recruiting
    • Breast Cancer
    • Castration-resistant Prostate Cancer
    • Bone modifying agent
    • Ottawa, Ontario, Canada
      The Ottawa Hospital Cancer Centre
    Apr 19, 2022

    HRR Prevalence in LatAm PROSPECT Study

    Completed
    • Castration-resistant Prostate Cancer
      • Ciudad Autónoma de Buenos Aires, Argentina
      • +10 more
      Apr 19, 2022

      Castration-Resistant Prostate Cancer Trial in Las Vegas, Port Jefferson Station (Enzalutamide or Abiraterone or Apalutamid)

      Recruiting
      • Castration-Resistant Prostate Cancer
      • Enzalutamide or Abiraterone or Apalutamid
      • Las Vegas, Nevada
      • +1 more
      Apr 4, 2022

      Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer Trial in Denmark, Finland, France

      Active, not recruiting
      • Prostate Cancer Metastatic
      • +3 more
      • Copenhagen, Denmark
      • +3 more
      Mar 23, 2022